Penumbra, Inc. (PEN)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Penumbra, Inc. (PEN) is up 2.7% since the beginning of the year. At $319 per share, PEN is trading 11.9% below its 52-week high of $362. Investors who bought $1,000 worth of PEN shares 5 years ago would now be looking at an investment worth $1,184.

Penumbra, Inc. (PEN) has returned 2.72% so far this year and 24.09% over the past 12 months. Looking at the last ten years, PEN has achieved an annualized return of 19.12%, outperforming the S&P 500 Index benchmark, which averaged 13.66% per year.

Based on dividend-adjusted daily data since Sep 18, 2015, PEN's average daily return is +0.11%, while the average monthly return is +2.31%. At this rate, an investment would double in approximately 2.5 years.

Historically, 55% of months were positive and 45% were negative. The best month was Jan 2021 with a return of +49.2%, while the worst month was Apr 2022 at -22.3%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 6 months.

On a daily basis, PEN closed higher 51% of trading days. The best single day was Nov 13, 2015 with a return of +23.7%, while the worst single day was Aug 8, 2018 at -16.1%.

Penumbra, Inc. has an annualized alpha of 15.59%, beta of 0.95, and R2 of 0.16 versus S&P 500 Index. Calculated based on daily prices since September 21, 2015.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (80.49%) than losses (30.64%) - typical of diversified or defensive assets.
• R2 of 0.16 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

PEN ranks 67 for risk / return — better than 67% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for Penumbra, Inc. (PEN) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Penumbra, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Penumbra, Inc. was 62.64%, occurring on Jun 16, 2022. Recovery took 224 trading sessions.

The current Penumbra, Inc. drawdown is 11.14%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Penumbra, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Penumbra, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.